Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
FOXO4-DRI is a synthetic peptide designed as a retro-inverso analog of the transcription factor FOXO4, in which naturally occurring L-amino acids are substituted with their D-enantiomers
Pericyte loss influences Alzheimer-like neurodegeneration in mice
Pegsebrenatide is being developed by Neuraly, whose CEO Seulki Lee described the program as targeting the neuroinflammatory processes that drive disability worsening in progressive forms of the disease
Presented for research literature review only Armstrong RN (1991)
US$ 25.38
US$ 25.46
US$ 20.41
